NAOV NanoVibronix Inc

Price (delayed)

$2.56

Market cap

$1.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$13.73

Enterprise value

$1.31M

NanoVibronix, Inc. is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface ...

Highlights
NanoVibronix's EPS has increased by 41% YoY
NAOV's debt is down by 8% since the previous quarter
NanoVibronix's revenue has decreased by 22% from the previous quarter but it has increased by 12% YoY
The equity has plunged by 84% YoY and by 67% from the previous quarter
NanoVibronix's quick ratio has plunged by 79% YoY and by 59% from the previous quarter

Key stats

What are the main financial stats of NAOV
Market
Shares outstanding
759,297
Market cap
$1.94M
Enterprise value
$1.31M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.39
Price to sales (P/S)
0.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.51
Earnings
Revenue
$2.56M
Gross profit
$1.51M
Operating income
-$3.58M
Net income
-$3.71M
EBIT
-$3.58M
EBITDA
-$3.58M
Free cash flow
-$2.52M
Per share
EPS
-$13.73
EPS diluted
-$13.73
Free cash flow per share
-$9.33
Book value per share
$1.84
Revenue per share
$9.48
TBVPS
$13.45
Balance sheet
Total assets
$3.63M
Total liabilities
$3M
Debt
$116,000
Equity
$627,000
Working capital
$609,000
Liquidity
Debt to equity
0.19
Current ratio
1.22
Quick ratio
0.31
Net debt/EBITDA
0.18
Margins
EBITDA margin
-140%
Gross margin
59%
Net margin
-144.8%
Operating margin
-140%
Efficiency
Return on assets
-73.2%
Return on equity
-167.6%
Return on invested capital
-400.9%
Return on capital employed
-394.9%
Return on sales
-140%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NAOV stock price

How has the NanoVibronix stock price performed over time
Intraday
-16.07%
1 week
-34.11%
1 month
-32.81%
1 year
-74.65%
YTD
-60.55%
QTD
-24.93%

Financial performance

How have NanoVibronix's revenue and profit performed over time
Revenue
$2.56M
Gross profit
$1.51M
Operating income
-$3.58M
Net income
-$3.71M
Gross margin
59%
Net margin
-144.8%
NAOV's operating margin has shrunk by 58% QoQ but it is up by 7% YoY
NAOV's net margin has dropped by 54% since the previous quarter but it is up by 11% year-on-year
NAOV's gross profit is down by 23% since the previous quarter
NAOV's operating income is down by 23% from the previous quarter and by 4.2% YoY

Growth

What is NanoVibronix's growth rate over time

Valuation

What is NanoVibronix stock price valuation
P/E
N/A
P/B
1.39
P/S
0.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.51
NanoVibronix's EPS has increased by 41% YoY
The equity has plunged by 84% YoY and by 67% from the previous quarter
NAOV's P/B is 45% below its 5-year quarterly average of 3.0 but 19% above its last 4 quarters average of 1.4
The P/S is 98% below the 5-year quarterly average of 13.6 and 47% below the last 4 quarters average of 0.6
NanoVibronix's revenue has decreased by 22% from the previous quarter but it has increased by 12% YoY

Efficiency

How efficient is NanoVibronix business performance
The ROE has dropped by 66% since the previous quarter and by 36% year-on-year
NanoVibronix's ROS has plunged by 58% from the previous quarter but it has increased by 7% YoY
NanoVibronix's ROIC has decreased by 46% from the previous quarter and by 30% YoY
The ROA has contracted by 38% from the previous quarter and by 12% YoY

Dividends

What is NAOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NAOV.

Financial health

How did NanoVibronix financials performed over time
NanoVibronix's total assets is 21% more than its total liabilities
NanoVibronix's quick ratio has plunged by 79% YoY and by 59% from the previous quarter
The current ratio has dropped by 54% year-on-year and by 30% since the previous quarter
NAOV's debt is 81% smaller than its equity
NAOV's debt to equity has surged by 171% since the previous quarter
The equity has plunged by 84% YoY and by 67% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.